BioAtla, Inc. (BCAB) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$48.20M | +33.0% |
| 2024 | -$71.94M | +30.8% |
| 2023 | -$104.02M | -15.0% |
| 2022 | -$90.42M | -45.3% |
| 2021 | -$62.21M | -71.2% |
| 2020 | -$36.33M | -276.7% |
| 2019 | -$9.64M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$48.20M | +33.0% |
| 2024 | -$71.94M | +30.8% |
| 2023 | -$104.02M | -15.0% |
| 2022 | -$90.42M | -45.3% |
| 2021 | -$62.21M | -71.2% |
| 2020 | -$36.33M | -276.7% |
| 2019 | -$9.64M | — |